National Research Corporation $NRC Shares Bought by Signaturefd LLC

Signaturefd LLC grew its stake in National Research Corporation (NASDAQ:NRC) by 31.4% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,531 shares of the company’s stock after purchasing an additional 1,084 shares during the period. Signaturefd LLC’s holdings in National Research were worth $76,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of the stock. Strs Ohio acquired a new position in National Research in the 1st quarter valued at $33,000. Aviso Financial Inc. boosted its holdings in National Research by 37.2% in the 1st quarter. Aviso Financial Inc. now owns 3,076 shares of the company’s stock valued at $39,000 after purchasing an additional 834 shares in the last quarter. Cubist Systematic Strategies LLC purchased a new stake in National Research in the 1st quarter valued at approximately $118,000. Significant Wealth Partners LLC acquired a new position in National Research during the 1st quarter worth approximately $131,000. Finally, M&T Bank Corp acquired a new stake in shares of National Research in the 1st quarter valued at approximately $164,000. 47.26% of the stock is owned by institutional investors and hedge funds.

National Research Trading Down 2.0%

NASDAQ NRC opened at $12.21 on Monday. The stock has a market cap of $281.56 million, a P/E ratio of 16.07 and a beta of 0.41. The company’s fifty day simple moving average is $14.67 and its 200-day simple moving average is $14.18. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 3.61. National Research Corporation has a 52 week low of $9.76 and a 52 week high of $21.64.

National Research (NASDAQ:NRC) last released its quarterly earnings results on Monday, July 28th. The company reported $0.28 earnings per share (EPS) for the quarter. The firm had revenue of $34.04 million for the quarter. National Research had a net margin of 12.78% and a return on equity of 83.52%.

National Research Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 10th. Shareholders of record on Friday, September 26th will be paid a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 3.9%. The ex-dividend date is Friday, September 26th. National Research’s dividend payout ratio (DPR) is 63.16%.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “sell (d)” rating on shares of National Research in a report on Saturday, September 27th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock presently has a consensus rating of “Sell”.

National Research Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.